Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 59.10

+7.2%

10:46 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry Liebman who wrote (515)	1/20/2000 8:45:00 AM
From: Jim Oravetz	of 52153

AVI BioPharma Inc. (AVII) 12 1/4 +2 5/32: Interest in biotechnology stocks remains very strong as these issues continue to provide day traders with new opportunities for a quick profit. Any time a press release is issued with regards to new discoveries or studies, you can bet that day traders will quickly discover the stocks that are most likely impacted by the results and ride them higher..... .....While the company certainly has reason to cheer about, the stock appears a bit overdone, considering the appreciation in the past week alone and the fact that Cruttenden Roth only had a 12-month price target of $11. Still, as long as traders remain eager to chase stocks in the biotech area, moves like the one seen in this issue are likely to continue until the craze passes, regardless of what the company's fundamentals may otherwise suggest. This traders game of trying to garner profits is also fueling the wild swings in biotech issues. Look at the action on VPHM this week, and CRGN ($95-130->93 in a day)last week. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next